Winner Medical

Winner Medical

Winner Medical was founded in 1991 by Li Jianquan, who has chaired the company since inception, steering it into a vertically integrated manufacturer of wound care, surgical, and infection-prevention products. The wealth originates from mass-scale production of cotton gauze, bandages, and nonwoven disposables distributed through hospital and retail channels globally. Li and his wife Ping Tse consolidate their equity through Winner Holding Limited and Glory Ray Holdings Limited, vehicles that also facilitated the company's 2018 privatization from the Shenzhen Stock Exchange and subsequent 2020 re-listing (per public record). Strategic deployment flows in two directions: operational expansion of the core manufacturing base and acquisition of supporting real assets. The company operates major production campuses including the Winner Industrial Park in Shenzhen's Longhua District and a manufacturing plant within the Texhong-Hai Ha Industrial Park in Quang Ninh, Vietnam, serving Southeast Asian supply chains. A production facility in Huanggang, Hubei further concentrates capacity for wound-care product lines. The commercial footprint extends to the Huilong Business Center, a 42nd-floor office near Shenzhen North Railway Station. These holdings reflect a commitment to direct operational control rather than financial portfolio allocation — Winner Medical procures, builds, and manages its own factories. Scale is difficult to disaggregate because investment assets and operating assets are not ring-fenced. Li Jianquan's personal net worth has placed him on multiple China rich lists, though the precise AUM attributable to investment activities is not published. The group employs a captive industrial workforce across at least four named campuses. Adjacent activities include the Winner Charity Association, which coordinates philanthropic efforts through the Guangdong Hakka Chamber of Commerce, and the JQ Library built in Li's ancestral home of Xishui County, Huanggang. The firm holds a Vice President seat in the Shenzhen Association of Medical Devices, signaling active participation in regional regulatory and trade matters. The structural differentiator is the absence of a formalized family-office chassis. Rather than segregating operating cash flows into a discrete investment entity with a mandate to diversify, Winner Medical reinvests corporate profits into tangible industrial and commercial real estate that supports its manufacturing core. This blurs the line between the family's operating company and its capital deployment, creating a succession challenge concentrated in a single, heavily operational CEO slot. The next-generation structure for splitting control of the operating business from the accumulated real estate portfolio remains undisclosed.